ASK1 Deficiency in Podocytes Reduces Glomerular Macrophages, but not Albuminuria or Glomerulosclerosis, in Early Type 1 Diabetic Kidney Disease
Natasha de Zoysa, Frank Y Ma, Elyce Ozols, Luise A Cullen-McEwen, John F Bertram, David J Nikolic-Paterson, Gregory H TeschBackground:
ASK1/p38 MAPK signaling promotes glomerular and tubulointerstitial injury in experimental models of acute and chronic kidney disease. In particular, ASK1 inhibitor treatment protects against albuminuria, podocyte loss, and glomerulosclerosis in models of diabetic kidney disease. Furthermore, p38 MAPK activation in podocytes has been demonstrated in both human and experimental diabetic kidney disease (DKD), suggesting a role of ASK1 signaling in podocyte injury. To investigate this hypothesis, we examined mice with conditional
Methods:
DKD was induced by low-dose streptozotocin injections in
Results:
Efficient
Conclusion:
Podocyte ASK1/p38 MAPK signaling promotes glomerular macrophage accumulation but does not influence albuminuria or glomerulosclerosis in a model of early DKD.